CDK9-IN-25 (compound 4a), an imidazopyrazine derivative, functions as a CDK9 inhibitor with an IC50 of 0.24 µM. It also exhibits affinity for the main protease of COVID-19 and demonstrates antiviral activity against human coronavirus 229E, with an IC50 o
Molecular Weight:
285.32
Formula:
C15H16FN5
Target:
Virus Protease
* VAT and and shipping costs not included. Errors and price changes excepted
